Clinical Trial Update: Extended Dose Intervals With Oral Cholera Vaccine in Cameroon [Phase 2]

View source ↗

Summary

Phase 2 trial update examining extended dosing intervals for the oral cholera vaccine conducted in Cameroon, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholera

Snippet

Sponsor: Johns Hopkins Bloomberg School of Public Health | Conditions: Adverse Reaction to Cholera Vaccine, Cholera Vaccination Reaction | Phase 2 | Status: COMPLETED